𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors

✍ Scribed by Diana M. Gitig; Andrew Koff

Book ID
111640213
Publisher
Humana Press Inc
Year
2001
Tongue
English
Weight
117 KB
Volume
19
Category
Article
ISSN
1073-6085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Inhibitors of cyclin-dependent kinase an
Inhibitors of cyclin-dependent kinase and cancer
✍ J. R. Biggs; A. S. Kraft πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 621 KB

Recent research has yielded a dramatic increase in the number of connections between oncogenesis and the proteins which regulate the cell cycle. Three classes of protein which inhibit the activity of cyclin-dependent kinases (CDKs) have emerged as potential targets for oncogenic inactivation. p16 an

Targets of the cyclin-dependent kinase C
Targets of the cyclin-dependent kinase Cdk1
✍ Ubersax, Jeffrey A.; Woodbury, Erika L.; Quang, Phuong N.; Paraz, Maria; Blethro πŸ“‚ Article πŸ“… 2003 πŸ› Nature Publishing Group 🌐 English βš– 360 KB
2-Aminoquinazoline Inhibitors of Cyclin-
2-Aminoquinazoline Inhibitors of Cyclin-Dependent Kinases.
✍ Yadagiri Bathini; Inderjit Singh; Patricia J. Harvey; Paul R. Keller; Rajeshwar πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons βš– 13 KB πŸ‘ 1 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

Cyclin-dependent kinase inhibitors for t
Cyclin-dependent kinase inhibitors for treating cancer
✍ Peter L. Toogood πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 242 KB

## Abstract Cyclin dependent kinases (Cdks) are essential enzymes for the control of cell cycle progression. Inhibitors of cyclin‐dependent kinases are anticipated to possess therapeutic utility against a wide variety of proliferative diseases, especially cancer. The field of published small molecu